Tibiofemoral

✅ Relieves menopausal symptoms
✅ Maintains bone density
✅ Reduces osteoporosis risk

Tibofem contains Tibolone

Product Overview:

Tibofem is a pharmaceutical preparation containing Tibolone as its active component. Designed for hormone replacement therapy (HRT), it effectively addresses menopausal symptoms and helps prevent bone density reduction caused by declining estrogen levels.

Indications:

This medication is indicated for:
– Relief of menopausal symptoms including hot flashes, vaginal atrophy, and emotional instability
– Preservation of bone mineral density
– Osteoporosis risk reduction in postmenopausal women

Administration Guidelines:

Administer Tibofem precisely as directed by your healthcare professional. The tablets may be taken with or without meals. Strict adherence to prescribed dosing schedules is essential for optimal therapeutic outcomes.

Mechanism of Action:

Tibolone, the pharmacologically active compound in Tibofem, is a synthetic steroid with selective tissue activity. It exhibits estrogenic, progestogenic, and androgenic properties through receptor modulation, effectively compensating for hormonal deficiencies during menopause while protecting skeletal integrity.

Dosage Protocol:

Dosage regimens are individualized based on therapeutic requirements and patient-specific factors. Medical supervision is mandatory throughout the treatment course to ensure appropriate dosing and duration.

Therapeutic Advantages:

  • Effective symptomatic relief during menopausal transition
  • Preservation of bone mineral content
  • Prophylaxis against postmenopausal osteoporosis

Frequently Reported Adverse Effects:

Common adverse reactions may include:
– Cephalalgia (headache)
– Mammary gland tenderness
– Breakthrough bleeding
– Emotional lability

Persistent or severe symptoms warrant immediate medical consultation.

Precautions and Contraindications:

Comprehensive medical evaluation is required prior to initiation, particularly for patients with:
– History of hormone-dependent neoplasms
– Thromboembolic disorders
– Hepatic impairment

Absolute contraindications and risk factors must be carefully evaluated by a qualified physician.

Storage Conditions:

Maintain at controlled room temperature (15-30°C) in original packaging. Protect from humidity and direct light. Store in secured location inaccessible to pediatric patients and animals.

Medical Disclaimer:

The provided information represents carefully vetted, scientifically validated data intended for educational purposes only. This content does not substitute professional medical advice, diagnosis, or treatment. Complete drug profiles including all potential adverse reactions, contraindications, and drug interactions may not be fully enumerated herein. Always consult your healthcare provider regarding therapeutic decisions and health concerns. This information aims to facilitate, not replace, the essential dialogue between patients and their medical practitioners.

Strength

2.5 mg

Quantity

28 Tablet/s, 56 Tablet/s, 84 Tablet/s

Pharma Form

Tablet/s

Manufacturer

Cipla Inc

Treatment

Hormone replacement therapy, Post menopausal osteoporosis

Generic Brand

Tibolone

Reviews

There are no reviews yet

Add a review
Tibiofemoral Tibiofemoral
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please confirm that you are not a robot